mattwilson2287 Profile Banner
Matt Wilson Profile
Matt Wilson

@mattwilson2287

Followers
881
Following
2K
Media
34
Statuses
613

Consultant haematologist specialising in lymphoma, Beatson WoSCC

Glasgow, Glasgow City
Joined June 2009
Don't wanna be here? Send us removal request.
@mattwilson2287
Matt Wilson
1 month
RT @graham74GC: It’s back and it’s online. The fantastic #lymphomaManagement course. With much thanks to @LymphomaAction for their suppor….
0
8
0
@mattwilson2287
Matt Wilson
3 months
Nice to see this published. Is there still a role for CNS prophylaxis in diffuse large B-cell lymphoma?.A debate with Dr Jeff Smith in @TheLancetHaem .
Tweet media one
3
7
49
@mattwilson2287
Matt Wilson
7 months
RT @DrAEvens: 🚨🚨🚨 The January 2025 edition of @BrJHaem is online. SEE HERE:. A multitude of outstanding contributi….
0
12
0
@mattwilson2287
Matt Wilson
8 months
Couldn't agree more! #RAdiCAL.
@ProfChrisPFox
Chris Fox
8 months
Time for biological-risk-informed real-time interventional studies. Time to be #RAdICAL. @DanielHodson20 @AndyD1036 @SFBarringtonKCL @mattwilson2287 @graham74GC @wendster @SridharChaganti #WillTownsend et al @SouthamptonCTU.
0
0
0
@mattwilson2287
Matt Wilson
8 months
RT @ProfChrisPFox: Time for biological-risk-informed real-time interventional studies. Time to be #RAdICAL. @DanielHodson20 @AndyD1036 @S….
0
3
0
@mattwilson2287
Matt Wilson
9 months
RT @BritSocHaem: We have published a new GPP on the Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity….
0
3
0
@mattwilson2287
Matt Wilson
9 months
Glad to finally have axi-cel available in second line DLBCL for our patients in Scotland, ensuring equity across the UK. Thanks @bloodcancer_uk.
@BloodCancer_Res
Blood Cancer UK Research
9 months
Amazing news of two new treatments approved for NHS use in Scotland: Yescarta (axi-cel) as a second line lymphoma treatment.Vanflyta (quizartinib) for newly-diagnosed AML. Delighted to have played our part in championing blood cancer patients' needs
Tweet media one
1
2
28
@mattwilson2287
Matt Wilson
9 months
RT @BloodCancer_Res: Amazing news of two new treatments approved for NHS use in Scotland: Yescarta (axi-cel) as a….
0
14
0
@mattwilson2287
Matt Wilson
9 months
RT @graham74GC: Impressive outcomes for ACOPP in older pts with Hodgkin. 41pts, 2y PFS 83%. Some toxicity seen though - 34% FN. great work….
0
5
0
@mattwilson2287
Matt Wilson
10 months
RT @CwynKate: BSH Lymphoma SIG MDT Dilemmas .Live webinar Thurs 10Oct 1800-19:30. Management of asymp low tumour burden FL: Kirit Ardeshna….
0
7
0
@mattwilson2287
Matt Wilson
11 months
Brilliant to see off @Mc73James this morning on the Glasgow leg of his amazing tour for @CureLeukaemia. Incredible effort (especially with an injury!) and for such an important cause 👏 👏 👏.
1
0
5
@mattwilson2287
Matt Wilson
11 months
RT @bloodcancer_uk: This Blood Cancer Awareness Month, we’re launching a landmark new report: Taking blood cancer out of the shadows: A pla….
0
99
0
@mattwilson2287
Matt Wilson
1 year
RT @tobyeyre82: Kudos to @DrJamKothari for leading one of the very few prospective trials post cBTKi in R/R WM. V important contribution t….
0
4
0
@mattwilson2287
Matt Wilson
1 year
RT @Eddie_Cliff: Informative and sobering dataset on CNS relapse of DLBCL from a large French-German collaboration just published in @Leuke….
0
24
0